FDA approves twice-yearly shot of Gilead drug for HIV prevention
BioPharma Drive: Drug Pricing
JUNE 18, 2025
The clearance ushers in a closely-watched launch for Gilead, which aims to show a long-acting injection can upend a market dominated by oral medicines.
Let's personalize your content